This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2008 Jun 5;358(23):2482-94.

doi: 10.1056/NEJMra0706547.

Chemotherapy-induced nausea and vomiting

Paul J Hesketh¹

Affiliations

PMID: 18525044
DOI: 10.1056/NEJMra0706547

Review

Chemotherapy-induced nausea and vomiting

Paul J Hesketh. N Engl J Med. 2008.

. 2008 Jun 5;358(23):2482-94.

doi: 10.1056/NEJMra0706547.

Author

Paul J Hesketh¹

Affiliation

¹ Caritas St. Elizabeth's Medical Center, Boston, MA 02135, USA. phesketh@massmed.org

PMID: 18525044
DOI: 10.1056/NEJMra0706547

No abstract available

PubMed Disclaimer

Similar articles

Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
Navari RM. Navari RM. J Support Oncol. 2003 Jul-Aug;1(2):89-103. J Support Oncol. 2003. PMID: 15352652 Review.
Update on the management of chemotherapy-related nausea and vomiting: an emphasis on the new class of agents--neurokinin-1 receptor antagonists.
Gralla R. Gralla R. Clin Adv Hematol Oncol. 2006 Jul;4(7):507-8. Clin Adv Hematol Oncol. 2006. PMID: 17147235 No abstract available.
Neurokinin antagonism and chemotherapy-induced emesis.
Shanahan F, O'Sullivan GC. Shanahan F, et al. Am J Gastroenterol. 1999 Nov;94(11):3368-9. doi: 10.1111/j.1572-0241.1999.03368.x. Am J Gastroenterol. 1999. PMID: 10566748 No abstract available.
Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
Rubenstein EB. Rubenstein EB. Clin Adv Hematol Oncol. 2004 May;2(5):284-9. Clin Adv Hematol Oncol. 2004. PMID: 16163194 Review.
Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy.
de Wit R, Herrstedt J, Rapoport B, Carides AD, Carides G, Elmer M, Schmidt C, Evans JK, Horgan KJ. de Wit R, et al. J Clin Oncol. 2003 Nov 15;21(22):4105-11. doi: 10.1200/JCO.2003.10.128. Epub 2003 Oct 14. J Clin Oncol. 2003. PMID: 14559891 Clinical Trial.

See all similar articles

Cited by

Olanzapine Administration Reduces Chemotherapy-Induced Nausea Behavior in Rats.
Jaime-Lara RB, Borner T, Holland RA, Shaulson E, Brooks B, De Jonghe BC. Jaime-Lara RB, et al. Biol Res Nurs. 2021 Oct;23(4):584-595. doi: 10.1177/10998004211000443. Epub 2021 Apr 1. Biol Res Nurs. 2021. PMID: 33789505 Free PMC article.
Preliminary evaluation of a predictive blood assay to identify patients at high risk of chemotherapy-induced nausea.
Kutner T, Kunkel E, Wang Y, George K, Zeger EL, Ali ZA, Prendergast GC, Gilman PB, Wallon UM. Kutner T, et al. Support Care Cancer. 2017 Feb;25(2):581-587. doi: 10.1007/s00520-016-3442-5. Epub 2016 Oct 12. Support Care Cancer. 2017. PMID: 27734152
Physical Activity, Alcohol, and Cigarette Use in Urological Cancer Patients over Time since Diagnosis.
Adamczak BB, Kuźnik Z, Makles S, Wasilewski A, Kosendiak AA. Adamczak BB, et al. Healthcare (Basel). 2023 Dec 26;12(1):59. doi: 10.3390/healthcare12010059. Healthcare (Basel). 2023. PMID: 38200965 Free PMC article.
Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial.
Bakhshi S, Batra A, Biswas B, Dhawan D, Paul R, Sreenivas V. Bakhshi S, et al. Support Care Cancer. 2015 Nov;23(11):3229-37. doi: 10.1007/s00520-015-2714-9. Epub 2015 Apr 8. Support Care Cancer. 2015. PMID: 25851802 Clinical Trial.
Evidence-based management of chemotherapy-induced nausea and vomiting: a position statement from a European cancer nursing forum.
Vidall C, Dielenseger P, Farrell C, Lennan E, Muxagata P, Fernández-Ortega P, Paradies K. Vidall C, et al. Ecancermedicalscience. 2011;5:211. doi: 10.3332/ecancer.2011.211. Epub 2011 Apr 28. Ecancermedicalscience. 2011. PMID: 22276054 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information